CASCELLA ROBERT 4
Research Summary
AI-generated summary
Celestica (CLS) Director Robert Cascella Receives RSU Awards
What Happened
- Director Robert Cascella was granted a total of 677 derivative awards from Celestica (58 RSUs on May 19, 2026 and 619 director‑RSUs on May 20, 2026). Each grant is recorded at $0.00 (standard for restricted share units); there is no immediate cash purchase or sale value reported. These are awards (code A) rather than open‑market purchases or sales.
Key Details
- Transaction dates and prices: May 19, 2026 — 58 RSUs @ $0.00; May 20, 2026 — 619 D‑RSUs @ $0.00.
- Total awarded: 677 units (58 RSUs + 619 D‑RSUs).
- Shares owned after the transaction: not specified in the provided filing.
- Vesting / conversion notes:
- RSUs (58): 1/3 vests annually over 3 years from May 19, 2026 (F2).
- D‑RSUs (619): vest in full on the first anniversary of the May 20, 2026 grant (F4).
- RSUs convert to one common share or cash at the holder’s election; D‑RSUs convert to common shares on settlement (subject to the holder’s deferral election) or, at the issuer’s election, cash (F1, F3).
- Filing: Form 4 filed May 20, 2026 reporting grants on May 19–20; the filing was not flagged as late in the information provided.
Context
- These awards are compensation/retention grants, not open‑market buys or sales. RSUs/D‑RSUs are contingent rights that become shares (or cash) only upon vesting/settlement, so they do not represent immediately tradeable shares. Such grants are routine for directors and reflect compensation rather than direct buying or selling of stock.